Jim Kremidas, Executive Director, ACRP

Clinical Trials Need to Be More Representative of Our Population

We applaud the Sept. 2 op-ed by Rep. Karen Bass (D-Calif.) regarding the importance of promoting diversity in the clinical trial patient population [“Vaccine trials’ lack of diversity threatens their validity”]. It’s the right thing to do morally, and it will strengthen trial success rates by enhancing data and better mirroring the people our drugs […]

Jim Kremidas, ACRP Executive Director

Preserving Clinical Research Sites During the Coronavirus Pandemic

Before the coronavirus pandemic, clinical research sites were already operating on low margins, and often faced tight financial constraints and understaffed workforces. According to a survey by Society for Clinical Research Sites (SCRS) released in early April, 59% of sites in 2019 reported that they had three months or less of operating cash. […]

Jim Kremidas, Executive Director, ACRP

Oracle Survey Finds Investigative Sites Still Frustrated with eClinical Technology

"Sites are overwhelmed with too many solutions and ballooning login credentials," said Jim Kremidas, executive director, ACRP. "Instead of engaging with patients, an inordinate amount of time is spent learning new systems, completing redundant required training and reentering the same data multiple times. Simultaneously, pharmaceutical companies and CROs are left with a fragmented ecosystem of software, hardware, […]